Role of Atrial Natriuretic Peptide in Oxytocin Induced Cardioprotection

Heart Lung and Circulation

Volumn 24, Issue 1, 2015, Pages 86-93

  Houshmand, Fariba ^a   Faghihi, Mahdieh ^b   Zahediasl, Saleh ^c  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atrial natriuretic peptide; Ischaemia reperfusion; Oxidative stress; Oxytocin; Preconditioning

Indexed keywords

ANANTIN; ATOSIBAN; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; CREATINE KINASE MB; LACTATE DEHYDROGENASE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; OXYTOCIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ARGIPRESTOCIN; CARDIOTONIC AGENT; CYCLOPEPTIDE; ENZYME INHIBITOR; HORMONE ANTAGONIST; OXYTOCIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOTONIC AGENTS; ENZYME INHIBITORS; HORMONE ANTAGONISTS; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; OXYTOCICS; OXYTOCIN; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; VASOTOCIN;

EID: 84919599271     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.05.023     Document Type: Article

References (24)

1. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001, 81(2):629-683.
2. Gutkowska J., Jankowski M., Mukaddam-Daher S., McCann S. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res 2000, 33(6):625-633.
3. Houshmand F., Faghihi M., Zahediasl S. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides 2009, 30(12):2301-2308.
4. Favaretto A., Ballejo G., Albuquerque-Araujo W., Gutkowska J., Antunes-Rodrigues J., McCann S. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides 1997, 18(9):1377-1381.
5. Gutkowska J., Jankowski M., Lambert C., Mukaddam-Daher S., Zingg H.H., McCann S.M. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 1997, 94(21):11704-11709.
6. Haanwinckel M., Elias L., Favaretto A., Gutkowska J., McCann S., Antunes-Rodrigues J. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 1995, 92(17):7902-7906.
7. Nishikimi T., Maeda N., Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006, 69(2):318-328.
8. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006, 27(1):47-72.
9. de los Angeles Costa M., Bosc L.V.G., Majowicz M.P., Vidal N.A., Balaszczuk A.M., Arranz C.T. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 2000, 35(5):1119-1123.
10. Walker M., Curtis M., Hearse D., Campbell R., Janse M., Yellon D., et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988, 22(7):447-455.
11. Curtis M., Walker M. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 1988, 22(9):656-665.
12. Weber W., Fischli W., Hochuli E., Kupfer E., Weibel E. Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity. J Antibiot (Tokyo) 1991, 44(2):164-171.
13. Paquin J., Danalache B.A., Jankowski M., McCann S.M., Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA. 2002, 99(14):9550-9555.
14. Chowdrey H., Curtis M.J., Hearse D.J. Effects of atrial natriuretic peptide on ischaemia-induced arrhythmias in the rat heart: arrhythmogen or endogenous antiarrhythmic agent?. J Cardiovasc Pharmcol 1989, 13(3):451-454.
15. Takata Y., Hirayama Y., Kiyomi S., Ogawa T., Iga K., Ishii T., et al. The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion. Cardiovasc Res 1996, 32(2):286-293.
16. Kim H.S., Kwack S.J., Lee B.M. Lipid peroxidation, antioxidant enzymes, and benzo [a] pyrene-quinones in the blood of rats treated with benzo [a] pyrene. Chem Biol Interact 2000, 127(2):139-150.
17. Biyikli N.K., Tugtepe H., Sener G., Velioglu-Ogunc A., Cetinel S., Midillioglu S., et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides 2006, 27(9):2249-2257.
18. Szeto A., Nation D.A., Mendez A.J., Dominguez-Bendala J., Brooks L.G., Schneiderman N., et al. Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab 2008, 295(6). E1495-E501.
19. Tugtepe H., Sener G., Biyikli N.K., Yuksel M., Cetinel S., Gedik N., et al. The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regul Pept 2007, 140(3):101-108.
20. Yao Z., Gross G.J. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res 1993, 73(6):1193-1201.
21. Okawa H., Horimoto H., Mieno S., Nomura Y., Yoshida M., Sasaki S. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts. Mol Cell Biochem 2003, 248(1):171-177.
22. D'souza S.P., Yellon D.M., Martin C., Schulz R., Heusch G., Onody A., et al. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 2003, 284(5). H1592-H600.
23. Yang X.M., Philipp S., Downey J.M., Cohen M.V. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 2006, 101(4):311-318.
24. Alizadeh A.M., Faghihi M., Sadeghipour H.R., Mohammad Ghasemi F., Imani A., Houshmand F., et al. Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides 2010, 31(7):1341-1345.